{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:06:14Z","timestamp":1779912374061,"version":"3.53.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019954","name":"Ministerio de Educaci\u00f3n y Ciencias","doi-asserted-by":"publisher","award":["RFMEFI61614\u00d70010"],"award-info":[{"award-number":["RFMEFI61614\u00d70010"]}],"id":[{"id":"10.13039\/100019954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.phymed.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T15:09:21Z","timestamp":1450537761000},"page":"1198-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Anti-cytokine therapy for prevention of atherosclerosis"],"prefix":"10.1016","volume":"23","author":[{"given":"Tatiana V.","family":"Kirichenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor A.","family":"Sobenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2015.12.002_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/153100350601800124","article-title":"Carotid plaque morphologic characteristics","volume":"18","author":"Aidinian","year":"2006","journal-title":"Perspect. Vasc. Surg. Endovasc. Ther."},{"key":"10.1016\/j.phymed.2015.12.002_bib0002","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.STR.0000147965.52712.fa","article-title":"Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis","volume":"35","author":"Amarenco","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.phymed.2015.12.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/718329","article-title":"Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis","author":"Ammirati","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.phymed.2015.12.002_bib0004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on 10-year follow-up of the prospective cardiovascular Muenster (PROCAM) study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2015.12.002_bib0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/07853890.2010.523711","article-title":"Tumor necrosis factor superfamily molecules in acute coronary syndromes","volume":"43","author":"Aukrust","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0006","doi-asserted-by":"crossref","unstructured":"Azen, S.P., Qian, D., Mack, W.J., Sevanian, A., Selzer, R.H., Liu, C.R., Liu, C.H., Hodis, H.N., 1996. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering Circulation. 94, 2369\u20132372.","DOI":"10.1161\/01.CIR.94.10.2369"},{"key":"10.1016\/j.phymed.2015.12.002_bib0007","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","article-title":"Anti-inflammatory therapies for atherosclerosis","volume":"12","author":"Back","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","article-title":"Detection and localization of tumour necrosis factor in human atheroma","volume":"65","author":"Barath","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jep.2006.09.038","article-title":"Inhibition of the pro-inflammatory mediators\u2019 production and anti-inflammatory effect of the iridoid scrovalentinoside","volume":"110","author":"Bas","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/ATVBAHA.113.302700","article-title":"Interleukin 1 receptor 1 and interleukin 1\u03b2 regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans","volume":"34","author":"Beaulieu","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14728214.2013.801453","article-title":"Emerging anti-inflammatory drugs for atherosclerosis","volume":"18","author":"Berman","year":"2013","journal-title":"Expert. Opin. Emerg. Drugs."},{"key":"10.1016\/j.phymed.2015.12.002_bib0012","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1517\/13543784.7.10.1667","article-title":"The role of cytokines in unstable angina","volume":"7","author":"Biasucci","year":"1998","journal-title":"Expert. Opin. Investig. Drugs."},{"key":"10.1016\/j.phymed.2015.12.002_bib0013","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/hh2101.099270","article-title":"Novel clinical markers of vascular wall inflammation","volume":"89","author":"Blake","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0014","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-119-10-199311150-00002","article-title":"Coronary angiographic changes with lovastatin therapy. The monitored atherosclerosis regression study (MARS).","volume":"119","author":"Blankenhorn","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0015","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","article-title":"Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells","volume":"108","author":"Calabro","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2015.12.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/608979","article-title":"Food-derived bioactive peptides on inflammation and oxidative stress","author":"Chakrabarti","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phymed.2015.12.002_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2013.11.007","article-title":"Innate immune system cells in atherosclerosis","volume":"45","author":"Chavez-Sanchez","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0018","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(86)92426-8","article-title":"Atherogenicity of blood serum from patients with coronary heart disease","volume":"2","author":"Chazov","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2015.12.002_bib0019","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2015.05.064","article-title":"Ezetimibe and plaque regression: cholesterol lowering or pleiotropic effects?","volume":"66","author":"Crea","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0020","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI11871","article-title":"A major role for VCAM-1, but not ICAM-1, in early atherosclerosis","volume":"107","author":"Cybulsky","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2015.12.002_bib0021","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1194\/jlr.R500009-JLR200","article-title":"Thematic review series: the immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis","volume":"46","author":"Daugherty","year":"2005","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0022","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200009073431011","article-title":"The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1","volume":"343","author":"Dinarello","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1185\/030079902125000516","article-title":"Effects of fibrates on serum metabolic parameters","volume":"18","author":"Elisaf","year":"2002","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.phymed.2015.12.002_bib0024","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10787-015-0228-1","article-title":"Role of fish oil in human health and possible mechanism to reduce the inflammation","volume":"23","author":"Ellulu","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phymed.2015.12.002_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/cvr\/28.9.1301","article-title":"Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease","volume":"28","author":"Entman","year":"1994","journal-title":"Cardiovasc. Res."},{"issue":"8 Suppl","key":"10.1016\/j.phymed.2015.12.002_bib0026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0027","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.114.303568","article-title":"Treating atherosclerosis with regulatory T cells","volume":"35","author":"Foks","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0028","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2015.12.002_bib0029","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1749-6632.1994.tb17348.x","article-title":"Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions","volume":"748","author":"Galis","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.phymed.2015.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1373\/clinchem.2014.227116","article-title":"Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community","volume":"60","author":"Gopal","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phymed.2015.12.002_bib0031","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10517-007-0099-6","article-title":"Use of natural products in anticytokine therapy","volume":"143","author":"Gorchakova","year":"2007","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0032","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1538-7836.2009.03416.x","article-title":"Inflammatory mechanisms in atherosclerosis","volume":"1","author":"Hansson","year":"2009","journal-title":"J. Thromb. Haemost. Suppl."},{"key":"10.1016\/j.phymed.2015.12.002_bib0033","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5551\/jat.14001","article-title":"Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Huang\u0431","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.phymed.2015.12.002_bib0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/biof.1024","article-title":"Inflammatory markers in coronary artery disease","volume":"38","author":"Ikonomidis","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.phymed.2015.12.002_bib0036","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V86.4.1243.bloodjournal8641243","article-title":"IL-6 family of cytokines and gp130","volume":"86","author":"Kishimoto","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2015.12.002_bib0037","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0038","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phymed.2015.12.002_bib0039","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","article-title":"Monocyte and macrophage dynamics during atherogenesis","volume":"31","author":"Ley","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0040","doi-asserted-by":"crossref","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","article-title":"Inflammation and cardiovascular disease mechanisms","volume":"83","author":"Libby","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phymed.2015.12.002_bib0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajpath.2012.10.006","article-title":"Adaptive immunity and atherosclerosis: mouse tales in the AJP","volume":"182","author":"Lichtman","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9150(03)00012-1","article-title":"Circulating markers of inflammation and atherosclerosis","volume":"169","author":"Lind","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2015.12.002_bib0043","first-page":"158","article-title":"Carotid artery intima-media thickness - a new noninvasive gold standard for assessing the anatomic extent of atherosclerosis and cardiovascular risk","volume":"22","author":"Lonn","year":"1999","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0044","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1515\/CCLM.2004.081","article-title":"Beyond cholesterol - inflammatory cytokines, the key mediators in atherosclerosis","volume":"42","author":"Mangge","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0047","first-page":"951","article-title":"Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis","volume":"138","author":"Moyer","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0048","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0049","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/jmf.2014.0138","article-title":"Anti-atherosclerotic and anti-inflammatory actions of sesame oil","volume":"18","author":"Narasimhulu","year":"2015","journal-title":"J. Med. Food."},{"key":"10.1016\/j.phymed.2015.12.002_bib0050","first-page":"109","article-title":"Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion","volume":"1","author":"Nikoforov","year":"2013","journal-title":"Patol. Fiziol. Eksp. Ter."},{"key":"10.1016\/j.phymed.2015.12.002_bib0051","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(94)90206-2","article-title":"New models for predicting cardiovascular events","volume":"47","author":"Odell","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0052","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.66.2.311","article-title":"Trigger like stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells","volume":"66","author":"Orekhov","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0053","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/07853899509031938","article-title":"Direct anti-atherosclerosis-related effects of garlic","volume":"27","author":"Orekhov","year":"1995","journal-title":"Ann. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0054","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jvs.2012.08.045","article-title":"Statins and other agents for vascular inflammation","volume":"56","author":"Owens","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.phymed.2015.12.002_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene. Expr."},{"key":"10.1016\/j.phymed.2015.12.002_bib0056","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1024\/0301-1526\/a000439","article-title":"Markers of preclinical atherosclerosis and their clinical relevance","volume":"44","author":"Poredos","year":"2015","journal-title":"Vasa"},{"key":"10.1016\/j.phymed.2015.12.002_bib0057","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.2174\/1568026614666141203130324","article-title":"Pleiotropic effects of statins in atherosclerotic disease: focus on the antioxidant activity of atorvastatin","volume":"14","author":"Profumo","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phymed.2015.12.002_bib0058","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MOL.0b013e328359b0a6","article-title":"Effect of interleukin 1\u03b2 inhibition in cardiovascular disease","volume":"23","author":"Qamar","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"issue":"15","key":"10.1016\/j.phymed.2015.12.002_bib0059","first-page":"00032","article-title":"Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets","volume":"S1359-6101","author":"Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phymed.2015.12.002_bib0060","first-page":"1","article-title":"C-reactive protein and risks of future myocardial infarction and thrombotic stroke","volume":"19","author":"Ridker","year":"1998","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.phymed.2015.12.002_bib0061","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0062","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.phymed.2015.12.002_bib0063","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.10.5.680","article-title":"Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits","volume":"10","author":"Rosenfeld","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.phymed.2015.12.002_bib0064","first-page":"291","article-title":"Macrophagecolony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans","volume":"140","author":"Rosenfeld","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0021-9150(91)90066-C","article-title":"Tumor necrosis factor-alpha in human arterial wall with atherosclerosis","volume":"89","author":"Rus","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2015.12.002_bib0066","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/01.CIR.92.7.1758","article-title":"Kuopio atherosclerosis prevention study (KAPS). A population-based primary prevention trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries","volume":"92","author":"Salonen","year":"1995","journal-title":"Circulation."},{"key":"10.1016\/j.phymed.2015.12.002_bib0067","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-4800(89)90043-9","article-title":"Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells","volume":"50","author":"Tertov","year":"1989","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.phymed.2015.12.002_bib0068","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.2174\/0929867322666150415145814","article-title":"The role and predictive value of cytokines in atherosclerosis and coronary artery disease","volume":"22","author":"Tousoulis","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phymed.2015.12.002_bib0069","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1163\/1568560041352301","article-title":"Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis","volume":"12","author":"Tripathi","year":"2004","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phymed.2015.12.002_bib0070","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.2174\/138161212802481237","article-title":"Atherosclerosis as an inflammatory disease","volume":"18","author":"Tuttolomondo","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2015.12.002_bib0071","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tcm.2013.09.006","article-title":"Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition","volume":"24","author":"Violi","year":"2014","journal-title":"Trends. Cardiovasc. Med."},{"key":"10.1016\/j.phymed.2015.12.002_bib0072","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2174\/092986712800229005","article-title":"Anti-inflammatory iridoids of botanical origin","volume":"19","author":"Viljoen","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phymed.2015.12.002_bib0073","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/pr.55.1.5","article-title":"Interleukins in atherosclerosis: molecular pathways and therapeutic potential","volume":"55","author":"Von der Th\u00fcsen","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2015.12.002_bib0074","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5482\/HAMO-13-09-0050","article-title":"Inflammatory mechanisms in atherosclerosis","volume":"34","author":"Wolf","year":"2014","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.phymed.2015.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1053\/euhj.1999.2207","article-title":"Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6","volume":"21","author":"Woods","year":"2000","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.phymed.2015.12.002_bib0076","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.RES.73.1.205","article-title":"Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life","volume":"73","author":"Yoshizumi","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.phymed.2015.12.002_bib0077","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0037-1613256","article-title":"Cytokines in the pathogenesis of atherosclerosis","volume":"88","author":"Young","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phymed.2015.12.002_bib0078","doi-asserted-by":"crossref","first-page":"e14525","DOI":"10.1371\/journal.pone.0014525","article-title":"Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711315003700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711315003700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T13:26:07Z","timestamp":1656941167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711315003700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0944711315003700"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2015.12.002","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cytokine therapy for prevention of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}